Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Protara Therapeutics Inc., 3 years.
Protara Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 16, 2025 | Incyte Corp. | Open-market sale | −1,340 | $68.36 | $91,602 |
| Jul 15, 2025 | Incyte Corp. | Open-market sale | −1,192 | $69.86 | $83,273 |
| Jul 15, 2025 | Incyte Corp. | Shares withheld for tax | −1,141 | $68.25 | $77,873 |
| Jul 14, 2025 | Incyte Corp. | Shares withheld for tax | −922 | $69.98 | $64,522 |
| Jul 3, 2025 | Incyte Corp. | Open-market sale | −10,903 | $68.15 | $743,039 |
| Jul 2, 2025 | Incyte Corp. | Shares withheld for tax | −9,055 | $68.17 | $617,279 |
| Apr 1, 2025 | Incyte Corp. | Grant or award | +11,159 | — | — |
| Apr 1, 2025 | Incyte Corp. | Grant or award | +14,976 | — | — |
| Mar 14, 2025 | Incyte Corp. | Open-market sale | −461 | $67.85 | $31,279 |
| Mar 14, 2025 | Incyte Corp. | Open-market sale | −199 | $67.88 | $13,508 |
| Mar 14, 2025 | Incyte Corp. | Open-market sale | −19,147 | $67.68 | $1,295,869 |
| Jan 15, 2025 | Incyte Corp. | Shares withheld for tax | −3,158 | $72.46 | $228,829 |
| Dec 9, 2024 | Incyte Corp. | Shares withheld for tax | −1,510 | $72.11 | $108,886 |
| Nov 6, 2024 | Incyte Corp. | Option exercise | +1,424 | $72.27 | $102,912 |
| Nov 6, 2024 | Incyte Corp. | Option exercise | +2,256 | $68.62 | $154,807 |
Questions about Barry P. Flannelly
What boards is Barry P. Flannelly on?
Barry P. Flannelly sits on the board of Protara Therapeutics Inc.
How long has Barry P. Flannelly served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.